Tissue-specific synthesis and oxidative metabolism of estrogens.

@article{Jefcoate2000TissuespecificSA,
  title={Tissue-specific synthesis and oxidative metabolism of estrogens.},
  author={C. Jefcoate and J. Liehr and R. Santen and T. Sutter and J. Yager and W. Yue and S. Santner and R. Tekmal and L. Demers and R. Pauley and F. Naftolin and G. Mor and L. Berstein},
  journal={Journal of the National Cancer Institute. Monographs},
  year={2000},
  volume={27},
  pages={
          95-112
        }
}
Estrogen exposure represents the major known risk factor for development of breast cancer in women and is implicated in the development of prostate cancer in men. Human breast tissue has been shown to be a site of oxidative metabolism of estrogen due to the presence of specific cytochrome P450 enzymes. The oxidative metabolism of 17beta-estradiol (E2) to E2-3,4-quinone metabolites by an E2-4-hydroxylase in breast tissue provides a rational hypothesis to explain the mammary carcinogenic effects… Expand
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
TLDR
Observations of the direct effect of 4-OH-E(2) support the concept that metabolic activation of estrogens mediated by various cytochrome P450 complexes, generating through this pathway reactive intermediates that elicit direct genotoxic effects leading to transformation. Expand
Estrogen Metabolism: Does the Formation of Estrogen Quinone Provide a Potential Pathway to Breast Carcinogenesis?
Estrogen has long been implicated in the initiation of carcinogenesis in estrogen-sensitive tissues through receptor-mediated events (Girder and Brotherick, 2000). However recent studies indicateExpand
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview
TLDR
This review addresses the most recent findings on the identification of UGT enzymes that are responsible for the glucuronidation of E2 and its metabolites, and evidence regarding their potential role in breast cancer. Expand
Potential mechanisms of estrogen quinone carcinogenesis.
TLDR
The data suggest that other key protein targets for estrogen o-quinones could be redox-sensitive enzymes (i.e, GST P1-1, QR). Expand
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
TLDR
Evidence strongly indicates that estrogens can become endogenous tumor initiators when CE-3,4-Q react with DNA to form specific depurinating adducts, the first in vitro/in vivo model of estrogen-induced carcinogenesis in human breast epithelial cells. Expand
Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells
TLDR
The inhibitory effect provoked by NOMAC on the enzymes involved in the biosynthesis of E(2) (sulfatase and 17HSD pathways) in estrogen-dependent breast cancer, as well as the stimulatory effect on the formation of the inactive E(1)S, can open attractive perspectives for future clinical trials. Expand
Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis
TLDR
The results support the concept that metabolites of estradiol may act in concert with ER mediated mechanisms to induce breast cancer and are consistent with the hypothesis that mammary tumor development is primarily initiated by metabolism of estrogens to 4-CE and, then, to CE-3,4-quinones, which may react with DNA to induce oncogenic mutations. Expand
Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms
TLDR
The use of specific phytochemicals and dietary supplements can inhibit the risk of breast cancer not only by the modulation of several estrogen-activating enzymes but also through the induction of various cytoprotective enzymes that reestablish the homeostatic balance of estrogen metabolism via nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent and independent mechanisms. Expand
The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
TLDR
This study is the first to show that O-methylation of 2- OH E2 by COMT is protective against oxidative DNA damage caused by 2-OH E2, a major oxidative metabolite of E2. Expand
Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer
  • E. Cavalieri, E. Rogan
  • Medicine, Chemistry
  • The Journal of Steroid Biochemistry and Molecular Biology
  • 2011
TLDR
Substantial evidence demonstrates the mutagenicity of the estrogen metabolites and their ability to induce transformation of mouse and human breast epithelial cells, and tumors in laboratory animals. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 142 REFERENCES
4-Hydroxylation of estrogens as marker of human mammary tumors.
  • J. Liehr, M. Ricci
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1996
TLDR
It is found that microsomes prepared from human mammary adenocarcinoma and fibroadenoma predominantly catalyze the metabolic 4-hydroxylation of estradiol, which may indicate a mechanistic role of 4-Hydroxyestradiol in tumor development. Expand
Functional role of estrogen metabolism in target cells: review and perspectives.
TLDR
Some of the many actions of estradiol may not be caused by est radiol per se, but may result from the formation of active estrogen metabolite(s) which function as local mediators or may activate their own unique receptors or effectors. Expand
Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer
TLDR
Metaanalysis supported the conclusion that increased rates of oxidation of estradiol 17‐β to 2‐OH catechols supply the principal proximal human mammary carcinogens active after menarche, and ECE rose linearly exponentially with increasing cancer risk. Expand
Cytochrome P450 metabolism of estradiol in hamster liver and kidney.
TLDR
The data suggest that estrogen 2-hydroxylation in the hamster kidney is catalyzed by members of the CYP1A and CYP3A families, which also contribute to 4-hydoxylation, and that the majority of 4-Hydroxyestradiol formation in theHamster kidney may be catalyzing by a form(s) of the newly discovered CYP 1B family that has yet to be characterized. Expand
Molecular Mechanisms of Estrogen Carcinogenesis
TLDR
The examples demonstrate that the parent compounds and their metabolites cause both nongenotoxic cell proliferative effects as well as direct and indirect genotoxic effects, which illustrates the complex nature of estrogen carcinogenesis. Expand
Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.
: Evidence for a role of estrogen metabolism in hormonal carcinogenesis was obtained with the Syrian hamster as an in vivo model system. Both natural and synthetic estrogens are capable of inducing aExpand
Catecholestrogen synthesis and metabolism by human breast tumors in vitro.
TLDR
The enzymes responsible for the synthesis and metabolism of catecholestrogens are present in some breast tumor specimens, suggesting that in such tissues these metabolites may be formed in vivo. Expand
Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens.
  • J. Liehr
  • Biology, Medicine
  • European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation
  • 1997
TLDR
A mechanism for mammary carcinogenesis is examined, which emphasizes tumour initiation by metabolic activation of oestrogens in combination with cell transformation and growth stimulation by oestrogen receptor-mediated processes. Expand
Expression and regulation of aromatase and 17β-hydroxysteroid dehydrogenase type 4 in human THP 1 leukemia cells
TLDR
The expression of steroid metabolizing enzymes in myeloid cells is able to create a microenvironment which is uncoupled from dominating systemic estrogens, and may be relevant in the autocrine, paracrine or iuxtacrine cellular crosstalk of myeloids cells in their respective states of terminal differentiation. Expand
The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites.
TLDR
The hypothesis that estrogen-induced carcinogenesis is mediated by catechol estrogen metabolites is supported and the carcinogenic estrogen MOX is converted to catechl metabolites at lower rates than estradiol, but their methylation may be sterically hindered by the 11 beta-methoxy substituent. Expand
...
1
2
3
4
5
...